Intuitive Surgical, Inc. ($ISRG)

HR5343 would force Medicare to provide immediate 4-year coverage for FDA breakthrough devices, directly benefiting large medical device manufacturers by eliminating the current 1-3 year coverage lag. The bill passed the Ways & Means committee 37-3 but awaits floor action. Despite bearish recent price action (MDT -8.2%, ABT -11%, BDX -7.3% in 30 days), this bill represents a structural catalyst for device revenue acceleration.

→ CMS must provide Medicare coverage for breakthrough surgical robotics and associated instruments/accessories, reducing the reimbursement uncertainty that delays hospital purchasing decisions.

The MIRACLE Medical Technology Act of 2025 (HR661) is an early-stage House bill authorizing HHS to establish a U.S.-Israel healthcare product development collaboration program. It has no funding allocation, was referred to committee in January 2025, and has seen no further action. Market impact is negligible at this stage; any benefit to med-tech companies or CROs requires a future appropriations bill and a long legislative path.

→ The bill does not appropriate funding or mandate specific procurement; it only authorizes a coordination program subject to future appropriations. No direct economic effect on any obligated party until subsequent funding is passed.